http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007100153-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate | 2004-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007100153-A |
| titleOfInvention | PHARMACEUTICAL KIT FOR TREATMENT OF PIGMENT RETINITIS AND ITS APPLICATION |
| abstract | 1. Pharmaceutical kit for the treatment of retinitis pigmentosa, containing the enzymes nicotinamide adenine dinucleotide (Enzyme A), nicotinamide adenine dinucleotide phosphate (Enzyme B) and reduced glutathione (Enzyme C) in equal parts and agreed amounts suitable for administration of a) Enzyme A at a concentration of 0.25 to 0.35 mg in 0.4 ml saline for three days, at monthly intervals, for three months in each eye; b) Enzyme B one month after the last administration of Enzyme A at a concentration of 0.25 to 0.35 mg in 0.4 ml saline for three days, at monthly intervals, for three months in each eye; c) Enzyme C one month after the last administration of Enzyme B at a concentration of 0.9 to 1.1 mg in 0.4 ml of saline solution for three days, at monthly intervals, a course of three months in each eye.2. The kit according to claim 1, in which the concentration of Enzyme A is 0.3 mg in 0.4 ml of saline, the concentration of Enzyme B is 0.3 mg in 0.4 ml of saline and the concentration of Enzyme C is 1.0 mg in 0 .4 ml of saline.3. A kit according to claim 1, containing the said enzymes in lyophilized form, in quantities sufficient to carry out at least one series of administrations according to schemes a)-c), divided into equal parts, including for each enzyme the amount of enzyme sufficient for one three-month course, monthly or daily administration and, preferably, suitable doses of saline to dissolve these equal parts of the enzymes.4. A kit according to claim 1, containing said enzymes in lyophilized form, divided into one or more equals� |
| priorityDate | 2004-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.